Hereditary, Complete Deficiency of Complement Factor H Associated with Recurrent Meningococcal Disease
- 1 December 1989
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 30 (6) , 711-718
- https://doi.org/10.1111/j.1365-3083.1989.tb02480.x
Abstract
Complement factor H (β‐1H globulin) is an important regulatory protein which inhibits the spontaneous complement activation via the alternative pathway. We describe a 15‐year‐old girl without any detectable factor H in plasma. She has had two episodes of meningococcal disease, but is otherwise completely healthy. Secondary to the factor‐H deficiency, the levels of factor B, properdin, C3, and C5‐C9 were strongly reduced due to spontaneous in vivo activation of the alternative complement pathway. Plasma C3dg was strongly elevated in spite of the Factor‐H deficiency; apparently erythrocyte CR1 substitutes for factor H in C3 degradation. Neither C3 nor complement lesions were demonstrable on her erythrocytes which did, however, show increased, spontaneous haemolysis in vitro in citrate plasma, but not in serum. The patient is a single child and her parents, who are unrelated and healthy, had half‐normal levels of factor H. This reduction of factor H is sufficient to cause increased, spontaneous activation of the alternative pathway.This publication has 15 references indexed in Scilit:
- [50] Electron microscopy: Assays involving negative stainingPublished by Elsevier ,1988
- Combined homozygous factor H and heterozygous C2 deficiency in an Italian familyJournal of Clinical Immunology, 1988
- Complement C3b receptors on erythrocytes in patients with juvenile rheumatoid arthritisArthritis & Rheumatism, 1987
- Congenital properdin deficiency and meningococcal infectionClinical Immunology and Immunopathology, 1987
- A familial deficiency of complement factor HBiochemical Society Transactions, 1987
- H deficiency in two brothers with atypical dense intramembranous deposit diseaseKidney International, 1986
- On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.The Journal of Immunology, 1984
- Complement Deficiency States and InfectionMedicine, 1984
- Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3dScandinavian Journal of Clinical and Laboratory Investigation, 1984
- [38] Detection and quantitation of circulating immune complexes by the C1q-Protein A binding assay (C1q-PABA)Published by Elsevier ,1981